NO905378L - Fremgangsmaate for fremstilling av terapeutisk aktive diazinderivater - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive diazinderivater

Info

Publication number
NO905378L
NO905378L NO90905378A NO905378A NO905378L NO 905378 L NO905378 L NO 905378L NO 90905378 A NO90905378 A NO 90905378A NO 905378 A NO905378 A NO 905378A NO 905378 L NO905378 L NO 905378L
Authority
NO
Norway
Prior art keywords
alkyl
phenyl
formula
substituents
hydrogen
Prior art date
Application number
NO90905378A
Other languages
English (en)
Norwegian (no)
Other versions
NO905378D0 (no
Inventor
Rodney Brian Hargreaves
Bernard Joseph Mcloughlin
Stuart Dennett Mills
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of NO905378D0 publication Critical patent/NO905378D0/no
Publication of NO905378L publication Critical patent/NO905378L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Insulating Materials (AREA)
  • Vibration Prevention Devices (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
NO90905378A 1989-12-22 1990-12-12 Fremgangsmaate for fremstilling av terapeutisk aktive diazinderivater NO905378L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898929022A GB8929022D0 (en) 1989-12-22 1989-12-22 Diazine derivatives

Publications (2)

Publication Number Publication Date
NO905378D0 NO905378D0 (no) 1990-12-12
NO905378L true NO905378L (no) 1991-06-24

Family

ID=10668392

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90905378A NO905378L (no) 1989-12-22 1990-12-12 Fremgangsmaate for fremstilling av terapeutisk aktive diazinderivater

Country Status (21)

Country Link
US (1) US5252567A (cg-RX-API-DMAC7.html)
EP (1) EP0434341B1 (cg-RX-API-DMAC7.html)
JP (1) JPH03291277A (cg-RX-API-DMAC7.html)
KR (1) KR910011838A (cg-RX-API-DMAC7.html)
AT (1) ATE122672T1 (cg-RX-API-DMAC7.html)
AU (1) AU641960B2 (cg-RX-API-DMAC7.html)
CA (1) CA2032743A1 (cg-RX-API-DMAC7.html)
DE (1) DE69019489T2 (cg-RX-API-DMAC7.html)
DK (1) DK0434341T3 (cg-RX-API-DMAC7.html)
ES (1) ES2072993T3 (cg-RX-API-DMAC7.html)
FI (1) FI906306A7 (cg-RX-API-DMAC7.html)
GB (2) GB8929022D0 (cg-RX-API-DMAC7.html)
HU (1) HU207511B (cg-RX-API-DMAC7.html)
IE (1) IE904391A1 (cg-RX-API-DMAC7.html)
IL (1) IL96609A0 (cg-RX-API-DMAC7.html)
NO (1) NO905378L (cg-RX-API-DMAC7.html)
NZ (1) NZ236417A (cg-RX-API-DMAC7.html)
PT (1) PT96315B (cg-RX-API-DMAC7.html)
TW (1) TW215088B (cg-RX-API-DMAC7.html)
ZA (1) ZA909852B (cg-RX-API-DMAC7.html)
ZW (1) ZW19290A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022644D0 (en) * 1990-10-18 1990-11-28 Ici Plc Heterocyclic compounds
EP1654249A1 (en) * 2003-08-07 2006-05-10 Pharmacia & Upjohn Company LLC Anthelmintic and insecticide pyrimidine derivatives
US7741976B2 (en) * 2005-12-16 2010-06-22 Hunt Power, L.P. Server and method for processing meter data into a common format
MY195016A (en) 2014-08-04 2023-01-03 Nuevolution As Optionally Fused Heterocyclyl-Substituted Derivatives of Pyrimidine Useful for The Treatment of Inflammatory, Metabolic, Oncologic and Autoimmune Diseases
AU2020405446A1 (en) 2019-12-20 2022-05-26 Nuevolution A/S Compounds active towards nuclear receptors
BR112022012205A2 (pt) 2019-12-20 2022-09-13 Nuevolution As Compostos ativos para receptores nucleares
CA3174252A1 (en) 2020-03-31 2021-10-07 Nuevolution A/S Compounds active towards nuclear receptors
JP7713954B2 (ja) 2020-03-31 2025-07-28 ヌエヴォリューション・アクティーゼルスカブ 核内受容体に対して活性な化合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB815833A (en) * 1956-09-26 1959-07-01 Boots Pure Drug Co Ltd Phenanthridine compounds
BE492034A (cg-RX-API-DMAC7.html) * 1948-11-05
DE1445740A1 (de) * 1963-09-04 1968-11-28 Bayer Ag Verfahren zur Herstellung von Bispyrimidinium-Verbindungen
US4339453A (en) * 1979-07-23 1982-07-13 Merck & Co., Inc. Antimicrobial aminopyrimidinium salts
US4287338A (en) * 1980-03-10 1981-09-01 The Upjohn Company Sulfooxy-pyrimidinium, -pyridinium, and -triazinium hydroxide inner salts
FR2524467A1 (fr) * 1982-03-30 1983-10-07 Adir Polymethylene-imines disubstituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
US4503050A (en) * 1983-06-02 1985-03-05 Riker Laboratories, Inc. Substituted imidazo[1,2-c]pyrimidines
US4725600A (en) * 1984-07-13 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine compounds having activity as a cardiotonic anti-hypertensive cerebrovascular vasodilator and anti-platelet aggregation agent
WO1987001706A2 (en) * 1985-09-12 1987-03-26 The Upjohn Company C20 through c26 amino steroids
DE3703633A1 (de) * 1986-02-14 1987-08-20 Sandoz Ag Purin-derivate, ihre herstellung und sie enthaltende arzneimittel
US4729995A (en) * 1986-04-21 1988-03-08 Toyo Boseki Kabushiki Kaisha Pyrimidine 2,4-dioxamate compounds and pharmaceutical compositions
DE3629563A1 (de) * 1986-08-02 1988-02-04 Mildenberger & Willing Verpack Tragbarer verpackungsbeutel aus kunststoffolie und verfahren zu dessen herstellung
DE3639563A1 (de) * 1986-11-20 1988-06-01 Basf Ag N-arylsulfonyl-n'-pyrimidyl(triazinyl) -harnstoffe
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
DK0434341T3 (da) 1995-10-09
US5252567A (en) 1993-10-12
ZW19290A1 (en) 1991-09-18
TW215088B (cg-RX-API-DMAC7.html) 1993-10-21
ATE122672T1 (de) 1995-06-15
HUT56087A (en) 1991-07-29
HU207511B (en) 1993-04-28
FI906306A0 (fi) 1990-12-20
EP0434341B1 (en) 1995-05-17
KR910011838A (ko) 1991-08-07
PT96315B (pt) 1998-06-30
GB8929022D0 (en) 1990-02-28
DE69019489D1 (de) 1995-06-22
ES2072993T3 (es) 1995-08-01
IL96609A0 (en) 1991-09-16
ZA909852B (en) 1991-10-30
CA2032743A1 (en) 1991-06-23
JPH03291277A (ja) 1991-12-20
AU6791490A (en) 1991-06-27
EP0434341A1 (en) 1991-06-26
NO905378D0 (no) 1990-12-12
FI906306A7 (fi) 1991-06-23
IE904391A1 (en) 1991-07-03
GB9025810D0 (en) 1991-01-09
DE69019489T2 (de) 1995-09-21
PT96315A (pt) 1991-09-30
NZ236417A (en) 1994-04-27
AU641960B2 (en) 1993-10-07
HU908115D0 (en) 1991-06-28

Similar Documents

Publication Publication Date Title
AU582601B2 (en) Benzoxazol-and benzothiazolamine derivatives
NO894411D0 (no) Fremstilling av 3-piperidinyl-1,2-benzisoksazoler.
HU9801934D0 (en) Process for producing of herbicidal activity substituted aryl-halogenalkyl-pyrazol derivatives
HUT59139A (en) Process for producing tricyclic compounds and antimicrobial pharmaceutical compositions comprising same
NO905378D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive diazinderivater.
AU6671390A (en) 1,3,5-triazine derivatives, processes for their preparation and pharmaceutical compositions containing them
DE69024154D1 (de) Pyrimidoindolderivate und Verfahren zu ihrer Herstellung
PT73948A (en) Process for the preparation of biologically active heterobicyclic hydroximidates and thiolhydroximidates and carbamate ester derivatives thereof